Life Sciences Bioinformatics Software sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Bioinformatics Software
1.1 - About Life Sciences Bioinformatics Software sector
Companies in this category deliver software platforms that ingest, manage, and analyze high-volume genomics and other omics datasets for research and clinical workflows. Life Sciences Bioinformatics Software vendors provide scalable pipelines, secure collaboration, and compliant data governance to accelerate discovery and diagnostics. For M&A analysts assessing strategic buyers in this space, these solutions unify sequencing data, automate analysis, and surface interpretable results for faster, reproducible insights.
Offerings typically include genomic data lakes with ETL connectors to LIMS/ELN systems, workflow orchestration supporting WDL/CWL and Nextflow, variant calling and annotation services linked to knowledge bases, RNA-seq and single-cell analysis modules, multi-omics integration with proteomics and metabolomics, interactive visualization and reporting, API access for custom pipelines, and cloud/HPC resource management with autoscaling and cost controls. Vendors also embed auditing, encryption, and role-based access to meet HIPAA and GDPR requirements.
Primary customers include biopharma R&D groups, clinical genomics laboratories, and academic research institutes or CROs seeking scalable analysis at lower cost. These platforms reduce analysis cycle time, improve data quality and governance, enable reproducible pipelines across studies, and shorten time-to-insight for target discovery and clinical reporting. They also enhance compliance readiness and auditability, supporting validation workflows and secure data sharing between internal teams and external collaborators.
2. Buyers in the Life Sciences Bioinformatics Software sector
2.1 Top strategic acquirers of Life Sciences Bioinformatics Software companies
Helix
- Description: Provider of an enterprise genomics platform that enables health systems, life-science companies and payers to integrate genomic testing and intelligence into clinical workflows. The company delivers whole-exome diagnostics, precision medicine pathways, research networks and longitudinal clinico-genomic data to improve patient outcomes, reduce costs and create new revenue streams.
- Key Products:
- Helix Research Network: Enables organizations to share and analyze collective genomic intelligence, accelerating discoveries, advancing precision medicine and delivering clinical impact across diverse patient populations
- Helix Precision Pathway: Provides advanced genomic insights integrated into clinical decision-making, letting healthcare providers personalize care at scale and improve outcomes through genetic guidance
- Helix Diagnostics: Offers comprehensive whole-exome based genetic testing and reporting, simplifying ordering workflows while returning actionable health information that informs preventive strategies and targeted interventions
- Helix Genomic Advantage: Supplies payers with genomic analytics that identify high-risk populations, shift cost curves, reduce unnecessary treatments and drive growth through value-based member management
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Bioinformatics Software sector
M&A buyer group 1: LIMS
Elemental Machines
- Type: N/A
- Employees: ●●●●●
- Description: Provider of an intelligent operations platform that integrates IoT sensors, custom hardware and software to give labs, biopharma and manufacturing sites real-time monitoring, predictive analytics and actionable insights, transforming equipment oversight, compliance and operational efficiency from reactive to proactive.
- Key Products:
- Intelligent Operations Platform: IoT-connected hardware, sensors and software collect high-sample-rate data, unify physical-digital worlds and provide actionable insights that simplify, optimize and augment laboratory and manufacturing operations
- AI-Driven Predictive Analytics: Contextual anomaly detection, custom AI models and proactive maintenance insights forecast issues, reduce downtime and extend equipment lifespan while displaying real-time data in user-friendly dashboards
- Freezer Monitoring Solutions: Continuous cold-storage monitoring with alerts ensures freezer health, protects samples during off-hours and safeguards compliance for life-science laboratories
- Custom Dashboards: Highly configurable dashboards let users combine multiple data sources, monitor key metrics in real-time, tailor insights to workflows and simplify data-driven decision-making across environmental and utilization parameters.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Bioinformatics Software sector
3.1 - Buyout funds in the Life Sciences Bioinformatics Software sector
2.2 - Strategic buyer groups for Life Sciences Bioinformatics Software sector
4 - Top valuation comps for Life Sciences Bioinformatics Software companies
4.2 - Public trading comparable groups for Life Sciences Bioinformatics Software sector
Valuation benchmark group 1: Biologic Drug Discovery Tools Companies
Vazyme Biotech
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of biotechnology solutions specializing in the design, manufacture, and application of bioactive proteins and compounds. The company focuses on innovative enzyme-based solutions for clinical and molecular diagnostics, among other applications.
- Key Products:
- COVID-19 Solution: Comprehensive assay and diagnostic solutions for COVID-19 testing, including qPCR kits and antibodies
- Molecular Biology Solutions: Offering reagents for PCR, qPCR, and NGS applications, catering to research and diagnostic needs
- Custom Oligos: Providing custom oligonucleotide synthesis services with a focus on high-performance and precision
- Enzyme Technologies: Development and manufacturing of enzyme solutions for diverse biological applications
- Reagent Kits: Producing high-quality reagent kits for DNA and RNA extraction and sequencing.